¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Critical Path AIDS project."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • critical flicker fusion
    ÀÓ°èÇø®Ä¿À¶ÇÕ
  • critical fusion frequency
    ÀÓ°èÀ¶ÇÕºóµµ
  • critical illumination
    ÀÓ°èÁ¶¸í
  • critical membrane potential
    ÀӰ踷ÀüÀ§
  • critical micelle concentration
    ÀÓ°è¹Ì¼¿³óµµ, ÀÓ°èÀ¯È­¸³³óµµ
  • critical organ
    À§ÇèÀå±â
  • critical phenomenon
    ÀÓ°èÇö»ó
  • critical point
    ÀÓ°èÁ¡
  • critical pressure
    ÀÓ°è¾Ð
  • critical region
    1. °áÁ¤ÀûºÎÀ§ 2. ±â°¢¿ª
  • critical state
    ÀÓ°è»óÅÂ
  • critical temperature
    ÀÓ°è¿Âµµ
  • critical velocity
    ÀÓ°è¼Óµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • critical region
    °áÁ¤ÀûºÎÀ§, ±â°¢¿ª
  • critical speed
    À§Çè¼Óµµ
  • critical state
    ÀÓ°è»óÅÂ
  • critical velocity
    ÀÓ°è¼Óµµ
  • critical care medicine
    ÁßȯÀÚÀÇÇÐ
  • critical closing pressure
    ÀÓ°èÆó¼â¾Ð
  • critical flicker frequency
    ÀÓ°èÇø®Ä¿ºóµµ
  • critical flicker fusion
    ÀÓ°èÇø®Ä¿À¶ÇÕ
  • critical fusion frequency
    ÀÓ°èÀ¶ÇÕºóµµ
  • critical membrane potential
    ÀӰ踷ÀüÀ§
  • critical micelle concentration
    ÃÖÀú¹Ì¼¿Çü¼º³óµµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inclination of condyle path
    °ú·Î°æ»çµµ(Î¨ÖØÌËÞØöô).
  • inclination of lateral condyle path
    Ãø¹æ°ú·Î°æ»ç(µµ)(ö°Û°Î¨ÖØÌËÞØöô).
  • inclination of sagittal incisal path
    ½Ã»óÀýÄ¡·Î°¢(ãÅßÒôîöÍÖØÊÇ).
  • lateral condyle path
    ¿ÜÃø°ú·Î.
  • lateral incisal path
    Ãø¹æÀýÄ¡·Î(ö°Û°ôîöÍÖØ).
  • optical path
    ±¤·Î(ÎÃÖØ).
  • particle path
    ÀÔÀÚÅë·Î(í£í­÷×ÖØ).
  • path
    °æ·Î, Åë·Î, ÆÐ½º
  • pupillary reflex path
    µ¿°ø¹Ý»ç°æ·Î(¡­ÌèÖØ).
  • reflex path =r. pathway, r. tract
    ¹Ý»ç°æ·Î(ÚãÞÒÌèÖØ).
  • strionigral path
    ¼±»óÃ¼ÈæÁú·Î(àÊß¾ô÷ýÙòõÖØ).
  • critical abscess
    ºÐ¸®±â³ó¾ç(ºÐÀ̱â³ó¾ç).
  • critical absorption energy
    ÀÓ°èÈí¼ö¿¡³ÊÁö
  • critical age
    °»³â±â(ËÖæÄÑ¢).
  • critical angle
    ÀÓ°è°¢(ìúÍ£ÊÇ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CFF critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F...
cff critical flicker fusion; critical fusion frequency
ARP absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro...
EPL effective patient's life; equivalent path length; essential phospholipid; extensor pollicis longus; ...
OPD obstetric prediabetic; optical path difference; otopalatodigital [syndrome]; outpatient department; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LPP lateral perforant path
BCDDP Breast Cancer Detection Demonstration Project
CPP Collaborative Perinatal Project
HGP Human Genome Project
NCPP National Collaborative Perinatal Project
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • efferent path
    ¿ø½É °æ·Î
  • end path
    Á¾·Î
  • functionally generated path
    ±â´É ¿îµ¿·Î
  • incisor path recording apparatus
    Àý´Ü·Î ¹¦»ç±â
    Gysi´Â ÇÏ¾Ç ¿îµ¿À» ±âÇÏÇÐÀûÀ¸·Î ¿¬±¸Çϱâ À§ÇÏ¿© ÇÏ¾Ç ÀüÄ¡ºÎÀÇ ¿îµ¿ ±ËÀûÀ» ±³ÇÕÆò¸é ¹× Á¤Á߸鿡 À־ ±â·ÏÇÏ´Â ÀåÄ¡¸¦ °í¾ÈÇß´Ù. ¹¦»ç±â´Â ÇÏ¾Ç ±³ÇÕÁ¦ Àü¸é¿¡ ÀåÄ¡µÈ´Ù. ¹¦±âħÀÇ Çϳª´Â ±³ÇÕ Æò¸é¿¡ À־ÀÇ ÀüÄ¡ºÎ Ãø¹æ ¿îµ¿ÀÇ ±ËÀûÀ» ±â·ÏÇϱâ À§ÇÏ¿© »ó¹æ ±³ÇÕÁ¦¿¡ ÇÏÇâÀ¸·Î, ´Ù¸¥ Çϳª´Â Á¤Áß¸é »óÀÇ °³Æó ¿îµ¿ ±ËÀûÀÌ ±â·ÏµÇ°Ô²û ¿·À¸·Î ÇâÇÏ¿© ÀåÄ¡µÇ¾î ÀÖ´Ù.
  • inclination of sagittal incisal path
    ½Ã»ó ÀýÄ¡·Î °¢
    1. ÇϾÇÀÇ ÀüÁø ¿îµ¿¿¡ À־, ÇÏ¾Ç ÀüÄ¡Á¡Àº ÀüÇϹæÀ¸·Î À̵¿Çؼ­ ½Ã»ó ÀüÄ¡·Î °¢À» ±×¸®´Âµ¥ ±× Á¦ 1»óÀÌ ±³ÇÕ Æò¸é°ú ÀÌ·ç´Â °¢À» ½Ã»ó ÀüÄ¡·Î °¢À̶ó°í ÇÑ´Ù. Gysi¿¡ ÀÇÇϸé 40?~80?, Nakasawa¿¡ ÀÇÇϸé 0?~62?, Æò±Õ 34?ÀÌ´Ù. ¹«Ä¡¾Ç¿¡¼­´Â °íÀ¯ÀÇ ¼öÄ¡°¡ ¾øÀ¸³ª, ±¸Ä¡ºÎ ±³µÎ°æ»ç¿Í Á¤ºñ·ÊÀûÀ¸·Î °ü°èµÇ¾î, ÀÇÄ¡ÀÇ ±â´É°ú °ü°è°¡ ±íÀ¸¹Ç·Î µµÄ¡ ¹è¿­ ½Ã¿¡ Àû´çÈ÷ Á¶Àý, ¼³Á¤ÇÑ´Ù. Æò±Õ½Ä±³±³±â¿¡¼­´Â 10?ÀÇ °ÍÀÌ ¸¹´Ù. 2. ÇϾÇÀÇ Ãø¹æ ¿îµ¿ ½Ã¿¡ ÀüÄ¡Á¡Àº Á¿ìÃøÀÇ Àü¿ÜÇϹæÀ¸·Î À̵¿ÇÏ¿© ¼ÒÀ§ °íµñ¾ÆÄ¡¸¦ ±×¸°´Ù. ÀÌ¿¡ ÀÇÇÏ¿© ¾ò¾îÁø °¢ÀÇ ±³ÇÕ Æò¸é¿¡ Åõ¿µÇÑ °¢À» Ãø¹æ ÀýÄ¡·Î °æ»çµµ¶ó°í Çϸç, Gysi¿¡ ÀÇÇÏ¿© Æò±Õ 120?¶ó°í ÇÑ´Ù. ±¸Ä¡ºÎÀÇ ±³µÎ °æ»ç¿Í ¿ªºñ·ÊÀûÀÎ °ü°è¸¦ ³ªÅ¸³½´Ù.
  • milled-in path
    ±â·Ï·Î, ¸¶¸ð ±³ÇÕ·Î, ÀÚµ¿ ¸¶¸ð ±³ÇÕ ¸¸°î
    ÇϾǰñÀÌ ¿îµ¿À» ÇÒ ¶§, »ó´ëµÇ´Â ±³ÇÕ ¸é¿¡´Â Ä¡¾Æ³ª ¾î¶² ÀåÄ¡°¡ µÇ¾î ÀÖ¾î À̰ÍÀÌ ±³ÇÕÁ¦ÀÇ ±³ÇÕ ¸é¿¡ ÀÚµ¿ÀûÀ¸·Î Á¶°¢µÇ¾î ³ªÅ¸³­ »óÅÂ.
  • occlusal path registration
    ±³ÇÕ·Î ±â·Ï
    ȯÀÚ ±¸°­ ³»¿¡¼­ ´ëÇÕÄ¡¿¡ ÀÇÇÏ¿© wax¿¡ ÀαâµÇ°Å³ª ±â·ÏµÈ ±³ÇÕ·ÎÀÇ ±â·Ï.
  • path
    °æ·Î, Åë·Î, ÆÐ½º
    Áö³ª°¡´Â ¶Ç´Â Ⱦ´ÜÇϴ Ư¼öÇÑ Åë·Î. ½Å°æÇп¡¼­´Â ±¸½É¼º, ¶Ç´Â ¿ø½É¼ºÀ¸·Î ½Å°æ Ãæµ¿À» Àü´ÞÇÏ´Â ½Å°æ ¼¶À¯ÀÇ ÇÑ °æ·Î·Î¼­, ƯÈ÷ ±× °æ·ÎÀÇ µÎ°³³» ¹× ô¼ö³» ºÎºÐÀ» ¸»ÇÑ´Ù.
  • path of insertion
    »ðÀÔ·Î
    º¸Ã¶¹°ÀÌ Áö´ëÄ¡ÀÇ Ã³À½ Á¢ÃËÁ¡À¸·ÎºÎÅÍ ±¹¼Ò ÀÇÄ¡ÀÇ ·¹½ºÆ®¿Í ÀÇÄ¡»óÀÌ Á¦ À§Ä¡¿¡ µé¾î°¡´Â ÃÖÁ¾ ¾ÈÁ¤ À§Ä¡±îÁö º¸Ã¶¹°ÀÌ ¿òÁ÷ÀÌ´Â ¹æÇâ.
  • path of placement
    »ðÀÔ·Î
  • ray path
    ±¤¼±·Î
  • rotating path
    ȸÀü °æ·Î
  • rotational path removable partial denture
    ȸÀü °æ·Î·Î ÀåÂøÇÏ´Â °¡Ã¶¼º ºÎºÐ»ó ÀÇÄ¡
  • sagittal path of condyle
    °úµÎÀÇ ½Ã»ó·Î
    ÀúÀÛ ½Ã ÇϾǰñÀÇ °üÀý µ¹±âÀÇ ¿îµ¿ °æ·Î¸¦ ½Ã»ó¸é¿¡ Åõ¿µ½ÃŲ °Í. ¿Õ·Î¿Í º¹·Î¿Í´Â ´ë°³ÀÇ °æ¿ì ÀÏÄ¡ÇÏÁö ¾Ê°í, ¶Ç ¹Ýº¹ ÀúÀÛÇÒ ¶§ ¸ÅÀÏ µ¿ÀÏ °æ·Î¸¦ ÃëÇÑ´Ù°í´Â Á¤ÇØÁ® ÀÖÁö ¾Ê´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
AIDS dementia <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
AIDS dementia complex <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
aids-related complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of kaposi's sarcoma, signaling the transition to the full-blown aids.
(12 Dec 1998)
aids-related opportunistic infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis carinii pneumonia, kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with mycobacterium avium complex, microsporidium, and cytomegalovirus.
(12 Dec 1998)
AIDS-related virus An obsolete term for human immunodeficiency virus.
(05 Mar 2000)
aids serodiagnosis Immunologic tests for identification of HIV (HTLV-III/lav) antibodies. They include assays for HIV seropositivity and HIV seronegativity (elisa, immunofluorescence, immunoblot, etc.) that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of aids or aids-related complex.
(12 Dec 1998)
AIDS test <investigation> A test which is performed on a standard venipuncture blood specimen which detects the presence of antibodies to HIV (virus). This test may not be positive for 3 to 6 months after infection with HIV.
(27 Sep 1997)
aids vaccines Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced.
(12 Dec 1998)
audiovisual aids Auditory and visual instructional materials.
(12 Dec 1998)
communication aids for disabled Equipment that provides mentally or physically disabled persons, who cannot speak effectively, with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesisers. The output of such aids includes written words, artificial speech, language signs, morse code, and pictures.
(12 Dec 1998)
hearing aids Devices which amplify sound to help persons with hearing loss.
(12 Dec 1998)
lymphoma, aids-related B-cell lymphoid tumours that occur in association with aids. Patients often present with an advanced stage of disease and highly malignant subtypes including burkitt lymphoma, immunoblastic large-cell lymphoma, small non-cleaved-cell lymphoma and diffuse large-cell lymphoma. The tumours are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in aids is a complex result of ebv infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.
(12 Dec 1998)
critical 1. Denoting or of the nature of a crisis.
2. Denoting a morbid condition in which death is possible.
3. In sufficient quantity as to constitute a turning point.
(05 Mar 2000)
critical angle The angle of incidence at which a ray of light, in passing between two media, changes from refraction to total reflection.
Synonym: limiting angle.
(05 Mar 2000)
critical care Health care provided to a critically ill patient during a medical emergency or crisis.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • middle path
    Áßµµ
  • path
    ±æ;Åë·Î;Çà·Î
  • primrose path
    ȯ¶ôÀÇ ±æ;¹æÅÁ;³­ºÀ
  • critical
    ºñÆÇÀûÀÎ
  • critical
    ºñÆò(°¡)ÀÇ;Æò·ÐÀÇ;ºñÆÇÀûÀÎ;ºñÆò(°¨½Ä)·Â ÀÖ´Â;¾ö¹ÐÇÑ;È£µÇ°Ô ºñÆÇÇÏ´Â;ȤÆòÀûÀÎ;ÈìÀ» Àß Àâ´Â;À§±âÀÇ;¾Æ½½¾Æ½½ÇÑ;À§ÇèÇÑ;(º´ÀÌ)°íºñ¿¡ ÀÖ´Â;À§µ¶ÇÑ;°áÁ¤ÀûÀÎ;Áß´ëÇÑ;Áß¿äÇÑ;ºñ»ó½Ã¿¡ ºÒ°¡°áÇÑ;ÀÓ°èÀÇ
  • critical angle
    ÀÓ°è°¢
  • critical apparatus
    (¹®Çå ¿¬±¸¿¡¼­)¿¬±¸ÀÚ·á
  • critical eleven minutes
    À§ÇèÇÑ 11ºÐ°£(Âø·úÀü 8ºÐ°£+ÀÌ·úÈÄ 3ºÐ°£)
  • critical list
    ÁßÅ ȯÀÚÇ¥
  • critical mass
    ÀÓ°è Áú·®;¹Ù¶÷Á÷ÇÑ °á°ú¸¦ È¿°úÀûÀ¸·Î ¾ò±âÀ§ÇÑ ÃæºÐÇÑ ¾ç
  • critical philosophy
    (Ä­Æ®(ÆÄ)ÀÇ) ºñÆÇ öÇÐ
  • critical point
    ÀÓ°èÁ¡
  • critical pressure
    ÀÓ°è¾Ð
  • critical region
    ±â°¢¿ª;À§Ç迪(°¡¼³ °ËÁ¤¿¡ À־ÀÇ)
  • critical temperature
    ÀÓ°è ¿Âµµ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á